Unknown

Dataset Information

0

New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties.


ABSTRACT: Considering the allosteric regulation of mGlu receptors for potential therapeutic applications, we developed a group of 1,2,4-oxadiazole derivatives that displayed mGlu4 receptor positive allosteric modulatory activity (EC50 = 282-656 nM). Selectivity screening revealed that they were devoid of activity at mGlu1, mGlu2 and mGlu5 receptors, but modulated mGlu7 and mGlu8 receptors, thus were classified as group III-preferring mGlu receptor agents. None of the compounds was active towards hERG channels or in the mini-AMES test. The most potent in vitro mGlu4 PAM derivative 52 (N-(3-chloro-4-(5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl)phenyl)picolinamide) was readily absorbed after i.p. administration (male Albino Swiss mice) and reached a maximum brain concentration of 949.76 ng/mL. Five modulators (34, 37, 52, 60 and 62) demonstrated significant anxiolytic- and antipsychotic-like properties in the SIH and DOI-induced head twitch test, respectively. Promising data were obtained, especially for N-(4-(5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)picolinamide (62), whose effects in the DOI-induced head twitch test were comparable to those of clozapine and better than those reported for the selective mGlu4 PAM ADX88178.

SUBMITTER: Stankiewicz A 

PROVIDER: S-EPMC8667925 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

New 1,2,4-oxadiazole derivatives with positive mGlu<sub>4</sub> receptor modulation activity and antipsychotic-like properties.

Stankiewicz Anna A   Kaczorowska Katarzyna K   Bugno Ryszard R   Kozioł Aneta A   Paluchowska Maria H MH   Burnat Grzegorz G   Chruścicka Barbara B   Chorobik Paulina P   Brański Piotr P   Wierońska Joanna M JM   Duszyńska Beata B   Pilc Andrzej A   Bojarski Andrzej J AJ  

Journal of enzyme inhibition and medicinal chemistry 20221201 1


Considering the allosteric regulation of mGlu receptors for potential therapeutic applications, we developed a group of 1,2,4-oxadiazole derivatives that displayed mGlu<sub>4</sub> receptor positive allosteric modulatory activity (EC<sub>50</sub> = 282-656 nM). Selectivity screening revealed that they were devoid of activity at mGlu<sub>1</sub>, mGlu<sub>2</sub> and mGlu<sub>5</sub> receptors, but modulated mGlu<sub>7</sub> and mGlu<sub>8</sub> receptors, thus were classified as group III-prefer  ...[more]

Similar Datasets

| S-EPMC9916658 | biostudies-literature
| S-EPMC6047043 | biostudies-literature
| S-EPMC7680602 | biostudies-literature
| S-EPMC10816717 | biostudies-literature
| S-EPMC8668286 | biostudies-literature
| S-EPMC6739692 | biostudies-literature
| S-EPMC10014483 | biostudies-literature
| S-EPMC11868951 | biostudies-literature
| S-EPMC10058719 | biostudies-literature
| S-EPMC11684029 | biostudies-literature